Information Provided By:
Fly News Breaks for January 15, 2020
INSM
Jan 15, 2020 | 13:10 EDT
JMP Securities analyst Liisa Bayko reiterated a Market Outperform rating and $40 price target in Insmed Incorporated. Bayko said the Insmed is poised for an "exciting" 2020 with near-term data and a geographic expansion on the horizon. The analyst added that she recommends the shares as she believes Arikayce sales will continue to exceed expectations in 2020 and she likes the risk/reward of the upcoming bronchiectasis data.
News For INSM From the Last 2 Days
There are no results for your query INSM